Merck & Co., Inc. (MRK)
Merck & Co., Inc. reported revenue of $65.01B for the fiscal year ended Dec 31, 2025, up 1.3% from $64.17B the year before. Net income was $18.25B, a net margin of 28.1% (prior year: $17.12B). At the end of that fiscal year the company reported total assets of $136.87B and shareholders' equity of $52.61B.
Revenue
$65.01B
+1.3% vs prior year
Net income
$18.25B
Net margin 28.1%
Diluted EPS
$7.28
USD per share
Total assets
$136.87B
At Dec 31, 2025
Equity
$52.61B
At Dec 31, 2025
Shares outstanding
2,467M
As of Jul 31, 2026
Explore Merck & Co., Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Aug 7, 2026
- 10-QFiled May 4, 2026
- 10-KFiled Feb 24, 2026
- 10-QFiled Nov 5, 2025
- 10-QFiled Aug 5, 2025
- 10-QFiled May 2, 2025
Compare Merck & Co., Inc.
- PFEPFE vs MRK
- LLYLLY vs MRK
Source: SEC EDGAR XBRL company facts for CIK 310158 (raw data). Most recent filing in this dataset: 10-Q filed Aug 7, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.